Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

0.68
Delayed Data
As of Dec 09
 -0.08 / -10.53%
Today’s Change
0.61
Today|||52-Week Range
1.71
-51.77%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close0.76
Today’s open0.73
Day’s range0.66 - 0.76
Volume14,800
Average volume (3 months)20,915
Market cap$9.3M
Dividend yield--
Data as of 3:48pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-29.05%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.90

Competitors

 Today’s
change
Today’s
% change
ATOSAtossa Genetics Inc-0.01-0.56%
BVXVBiondVax Pharmaceuti...-0.01-0.27%
EVOKEvoke Pharma Inc0.000.00%
CYANCyanotech Corp0.000.00%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$0.00
Annual profit (last year)-$3.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts


Search for Jobs